Reports for HIKMA CANADA LIMITED
Company Name
HIKMA CANADA LIMITED
Totals |
||
Shortage reports |
104 |
|
| Actual shortage: | 20 (19%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 83 (80%) | |
Discontinuation Reports |
9 |
|
| To be discontinued: | 3 (33%) | |
| Discontinued: | 6 (67%) | |
| Reversed: | 0 (0%) | |
Late reports |
16 (14%) |
|
Overdue reports |
17 (74%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2023-08-03 | 2024-03-28 | 200978 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Actual shortage | 2025-03-24 | 2025-04-02 | 253333 |
| ERGONOVINE MALEATE INJECTION USP | 0.25MG | SOLUTION | Resolved | 2019-03-11 | 2019-04-18 | 78235 |
| ERGONOVINE MALEATE INJECTION USP | 0.25MG | SOLUTION | Resolved | 2021-05-14 | 2021-09-04 | 139434 |
| FENTANYL CITRATE INJECTION USP | 50MCG | SOLUTION | Resolved | 2018-08-22 | 2018-10-11 | 58777 |
| FENTANYL CITRATE INJECTION USP | 50MCG | SOLUTION | Resolved | 2019-02-05 | 2019-02-28 | 74781 |
| FENTANYL CITRATE INJECTION USP | 50MCG | SOLUTION | Actual shortage | 2023-10-02 | 2023-11-02 | 205826 |
| FUROSEMIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2017-12-22 | 2018-04-27 | 34270 |
| FUROSEMIDE INJECTION USP | 20MG | SOLUTION | Resolved | 2023-11-17 | 2024-02-14 | 210680 |
| FUROSEMIDE INJECTION USP | 20MG | SOLUTION | Actual shortage | 2025-01-14 | 2025-02-01 | 247669 |
| GENTAMICIN INJECTION USP | 10MG | SOLUTION | Resolved | 2020-11-09 | 2020-12-03 | 128174 |
| LACOSAMIDE INJECTION, USP | 10MG | SOLUTION | Actual shortage | 2024-10-30 | 2024-11-26 | 241553 |
| LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION | 5MG 50MCG | SOLUTION | Resolved | 2023-06-06 | 2024-10-03 | 193838 |
| LEVOFLOXACIN IN 5% DEXTROSE INJECTION | 5MG | SOLUTION | Resolved | 2024-11-13 | 2024-12-30 | 242878 |
| LEVOFLOXACIN IN 5% DEXTROSE INJECTION | 5MG | SOLUTION | Actual shortage | 2025-01-28 | 2025-01-29 | 248804 |
| LEVOFLOXACIN IN 5% DEXTROSE INJECTION | 5MG | SOLUTION | Actual shortage | 2025-03-04 | 2025-03-06 | 251894 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 20MG 0.01MG | SOLUTION | Resolved | 2017-12-22 | 2018-02-15 | 34258 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 20MG 0.01MG | SOLUTION | Resolved | 2018-03-08 | 2018-05-16 | 42273 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2018-02-15 | 2018-03-10 | 39953 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 0.01MG 20MG | SOLUTION | Actual shortage | 2021-05-14 | 2021-05-15 | 139438 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | 0.2% | SOLUTION | Discontinued | 2025-03-24 | 2025-04-07 | 253339 |
| BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | 0.2% | SOLUTION | Discontinued | 2025-03-24 | 2025-04-02 | 253342 |
| DORZOLAMIDE AND TIMOLOL EYE DROPS BP | 5MG 20MG | SOLUTION | Discontinued | 2024-11-01 | 2024-11-01 | 241852 |
| LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION | 5MG 50MCG | SOLUTION | Discontinued | 2024-10-01 | 2024-10-02 | 239073 |
| LATANOPROST OPHTHALMIC SOLUTION | 50MCG | SOLUTION | Discontinued | 2025-03-24 | 2025-04-02 | 253336 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-04-19 | 2024-04-22 | 225805 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165188 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165193 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165196 |
Showing 1 to 9 of 9